[1]
Kamaraj, H. et al. 2024. Feasibility of single low-dose olanzapine with triple antiemetic therapy for prevention of highly emetogenic chemotherapy-induced nausea and vomiting: a single-centre case series. Journal of Drug Delivery and Therapeutics. 14, 12 (Dec. 2024), 15–19. DOI:https://doi.org/10.22270/jddt.v14i12.6924.